Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

New Drug Application News Monitoring

Get by Email • RSS

Published on May 28, 2025

Mitsubishi Tanabe Pharma America Announces U.S. FDA Acceptance of New Drug Application Resubmission for Investigational ...

JERSEY CITY, N.J., May 28, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) resubmission for investigational ND0612, a 24 …

Source: WISC Channel 3000 - Wisconsin - Neutral
Published on May 28, 2025

U.S. FDA Accepts New Drug Application Under Priority Review for sevabertinib (BAY 2927088) in HER2-Mutant Non-Small Cell ...

Regulatory submission is based on positive results from the ongoing Phase I/II SOHO-01 trial in patients with advanced HER2-mutant non-small cell lung cancer (NSCLC). Investigational agent sevabertinib (BAY 2927088) is an oral, small molecule, tyrosine …

Source: The AI Journal - Pending
Published on May 28, 2025

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

• KHINDIVI is the first and only FDA-approved hydrocortisone oral solution • Commercial launch expected the week of June 2nd • Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocortisone) oral granules to exceed $50 million DEER PARK …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 27, 2025

UroGen Pharma Ltd. (URGN) Shares Crash Again Amid FDA’s ODAC Vote Against UGN-102, Company Facing Investor Scrutiny – ...

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- On May 21, 2025, investors in UroGen Pharma Ltd. (NASDAQ: URGN) saw the price of their shares crash 44% after the company announced that the FDA’s Oncologic Drugs Advisory Committee (“ODAC”) voted against the …

Distribution channels: Consumer Goods, Law ...
Published on 04:11 GMT

Guess which ASX 200 stock is jumping 10% on big news

This stock is catching the eye with a strong gain on Thursday. But why? Posted by James Mickleboro has been a Motley Fool contributor since late 2015. After studying economics at university back home in the United Kingdom, James came to live in Australia …

Source: The Motley Fool Australia - Neutral
Published on 04:11 GMT

Why Champion Iron, Clarity Pharmaceuticals, St Barbara, and Woodside shares are charging higher today

These shares are having a good session today. But why are investors buying them? Posted by James Mickleboro has been a Motley Fool contributor since late 2015. After studying economics at university back home in the United Kingdom, James came to live in …

Source: The Motley Fool Australia - Neutral
Published on 03:48 GMT

Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring ...

SAN FRANCISCO and SUZHOU, China, May 29, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of …

Source: Macau Business - Pro-Government
Published on May 28, 2025

HT-KIT Shows Activity in Rare KIT-Driven Cancers, Preclinical Data Finds

Preclinical data has shown compelling findings for HT-KIT, a proprietary antisense oligonucleotide therapy designed to silence aberrant KIT gene expression, among patients with rare and aggressive KIT-driven cancers, according to a news release from Hoth …

Source: Cure Today - Neutral
Published on May 28, 2025

Tracking Therapeutic Progress of Gene-Editing Agent PBGENE-DMD for Duchenne Muscular Dystrophy

Over the last few years, the therapeutic landscape for Duchenne muscular dystrophy (DMD) has expanded significantly, with several exon-skipping treatments and even a gene therapy available for patients with the disease. Despite these advancements, patients …

Source: NeurologyLive - Pending
Published on 00:07 GMT

Reaction: FDA approves roflumilast foam 0.3% for scalp, body psoriasis

Last week, the FDA approved Arcutis Biotherapeutics' roflumilast foam 0.3% to treat plaque psoriasis of the scalp and body in patients aged 12 years and older, adding a nonsteroidal, once-daily, phosphodiesterase-4 inhibitor to the provider toolkit.1,2 …

Source: Contemporary Pediatrics - Pending
Published on 01:02 GMT

Clinical Trial Monitoring: Should Randomization Be Included?

Developing a clinical trial’s effective monitoring plan can be overwhelming. The FDA acknowledges that while they require monitoring, their “regulations are not specific on how monitoring should be conducted.”1,2 Thus, it is challenging to understand what …

Source: Applied Clinical Trials - Pending
Published on May 28, 2025

Supernus Announces Paragraph IV ANDA Filings for Qelbree®

ROCKVILLE, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...
Published on May 28, 2025

Phase 3 trial of tebipenem HBr for cUTI stopped early for efficacy

GSK and Spero Therapeutics announced that the pivotal phase 3 PIVOT-PO trial (NCT06059846) of tebipenem pivoxil hydrobromide (HBr) for complicated urinary tract infection (cUTI) has been stopped early following an interim analysis of the data showing that …

Source: Urology Times - Pending
Published on May 28, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVN

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. (“Biohaven” or the “Company”) (NYSE: BHVN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581 …

Distribution channels: Consumer Goods, Law ...
Published on May 28, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UroGen Pharma Ltd. - URGN

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646 …

Distribution channels: Consumer Goods, Law ...
Published on May 28, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Travere Therapeutics, Inc. - TVTX

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Travere Therapeutics, Inc. (“Travere” or the “Company”) (NASDAQ: TVTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

Distribution channels: Consumer Goods, Law ...
Published on May 28, 2025

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference

SEATTLE and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …

Distribution channels:
Published on May 28, 2025

PIVOT-PO phase III study for tebipenem HBr stopped early for efficacy following review by Independent Data Monitoring ...

If approved, tebipenem HBr could be the first oral carbapenem antibiotic for US patients with complicated urinary tract infections (cUTIs) Data to be part of a planned US FDA filing in H2 2025 An estimated 2.9 million cases of cUTIs are treated annually …

Source: GSK - Pending
Published on May 28, 2025

Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet ...

Enrollment for SOL-R, the largest retinal TKI trial to date, supports randomization of at least 555 subjects SOL-1, Ocular’s first registrational trial in wet AMD, completed randomization in December 2024 and retention remains exceptional as the trial …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

04 days 21:36:06

Featured Releases

Got News to Share? · Submit · See All

Published on May 28, 2025 - 18:00 GMT

BestRx Pharmacy Software Announces Integration with Lansworth Pharma SelfServe’s Pharmaself24 Kiosk Solution

BestRx is pleased to announce a new integration with Lansworth Pharma SelfServe, an advanced automated prescription pickup solution. OAKBROOK, IL, UNITED STATES, May 28, 2025 /⁨EINPresswire.com⁩/ -- BestRx, a RedSail Technologies company and a leading …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 28, 2025 - 11:40 GMT

Key Market Driver in intravenous iron drugs Industry 2025: Rising Prevalence Of Risk Factors, Associated Mortality Rates

The Business Research Company's Intravenous Iron Drugs Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 28, 2025 - 23:43 GMT

Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with ...

Tokyo, Japan and Cambridge, UK, 29 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Neurocrine Biosciences, Inc. announced that it had presented new positive data from the Phase 2 study of NBI-1117568 in adults with …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 28, 2025 - 05:00 GMT

Vidac Pharma Reports Exceptional Pharmacokinetics of Almavid™ Drug Candidate in Real-World Clinical study

Revolutionary cancer treatment demonstrates potential for Almavid™ Drug Candidate application in solid tumors. Vidac pharma Holding Plc (XSTU:SYM: T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ) LONDON, UNITED KINGDOM, May 28, 2025 /⁨EINPresswire.com⁩/ -- …

Distribution channels: Business & Economy, Chemical Industry ...

Published on May 28, 2025 - 21:28 GMT

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

• KHINDIVI is the first and only FDA-approved hydrocortisone oral solution • Commercial launch expected the week of June 2nd • Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocortisone) oral granules to exceed $50 million DEER PARK …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 28, 2025 - 22:25 GMT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

Distribution channels: Consumer Goods, Law ...
Published on May 28, 2025 - 20:01 GMT

Corvus Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 28, 2025 - 19:29 GMT

Schizophrenia Drugs Market Research Report 2025-2035, Competitive Analysis of Prominent Players - Novartis, Johnson & ...

The "Schizophrenia Drugs Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The market is experiencing significant …

Distribution channels:

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 817,076,136 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 29, 2025 - 06:04 GMT

In-Depth Analysis Of The Global Continuous Positive Airway Pressure Devices Market: Key Drivers, Trends, Opportunities

The Business Research Company’s Continuous Positive Airway Pressure Devices Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /⁨EINPresswire.com⁩/ -- Are You Aware Of The …

Distribution channels: Business & Economy, Companies ...
Published on May 29, 2025 - 06:04 GMT

Hyperammonemia Treatment Market to Reach USD 2,450 Million by 2035 Amidst Growing Focus on Rare Disease Therapies | FMI

Hyperammonemia Treatment Market Outlook: Key Trends, Growth Drivers & Emerging Therapeutics from 2025 to 2035 NEWARK, DE, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global hyperammonemia treatment market is poised for significant …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 06:04 GMT

Hutchinson-Gilford Progeria Syndrome Market Set for Robust Expansion, Projected to Reach USD 261,956.6 Million by 2035

Emerging therapies and innovations drive Hutchinson-Gilford Progeria Syndrome market growth from 2025 to 2035 across diagnostics and treatment NEWARK, DE, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global hutchinson-gilford progeria …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 06:04 GMT

Global Laband Syndrome Therapeutics Market Set for Strong Growth Amid Advancements in Rare Disease Treatments | FMI

Laband Syndrome Therapeutics Market Set to Evolve with Innovation and Emerging Trends from 2025 to 2035 NEWARK, DE, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global laband syndrome therapeutics market is on a significant growth …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 06:03 GMT

Trillium Clinic Dermatology Launches Innovative AI Chatbot to Enhance Patient Communication

Revolutionizing Healthcare Accessibility with Cutting-Edge Technology CHAPEL HILL, NC, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- Trillium Clinic Dermatology is proud to announce the launch of its new AI chatbot on trilliumclinic.com, a …

Distribution channels: Beauty & Hair Care, Consumer Goods ...
Published on May 29, 2025 - 06:00 GMT

Spectruth DAO and Hippo Protocol Forge Strategic Partnership to Pioneer Epigenetic Research in PTSD

Spectruth DAO’s study uses saliva-based epigenetic testing, AI, and wearables to predict PTSD risk in military/veterans, enabling personalized care. KYIV, KYIV, UKRAINE, May 29, 2025 /⁨EINPresswire.com⁩/ -- Spectruth DAO, a leader in decentralized, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 29, 2025 - 05:48 GMT

Global Collateral Ligament Stabilizer System Market To Reach $2.80 Billion By 2029 With A Growth Rate Of 7.1%

The Business Research Company’s Collateral Ligament Stabilizer System Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /⁨EINPresswire.com⁩/ -- The collateral ligament …

Distribution channels: Business & Economy, Companies ...
Published on May 29, 2025 - 05:18 GMT

Thrombocytopenia Treatment Market to Surpass USD 10,611.9 Million by 2035 Rising Demand for Targeted Therapies | FMI

Explore growth drivers, innovations, and future trends shaping the Thrombocytopenia Treatment Market from 2025 to 2035 NEWARK, DE, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global thrombocytopenia treatment market is poised for …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 05:17 GMT

Dr DeCarlo Introduces Advanced Spinal Decompression Therapy to Relieve Sciatica and Disc-Related Pain in New City NY

NEW CITY, NY, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- DeCarlo Chiropractic, led by Dr. Chris DeCarlo, is proud to offer state-of-the-art spinal decompression therapy to residents of New City and Rockland County, NY. This non-invasive …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 05:03 GMT

Disposable EEG Electrode Market to Reach USD 1,277 Million by 2035, Driven by Rising Neurological Disorders | FMI

Explore key trends, rising demand, and growth outlook in the global disposable EEG electrode market from 2025 to 2035 NEWARK, DE, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global disposable EEG electrode market is on a steady growth …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 04:52 GMT

An Evening Showcasing Rhode Island’s Leading HealthTech Voices, Startups, and Investment Opportunities

Designed to promote connections, increase visibility for local startups, highlight area's unique collaborative energy NEWPORT, RI, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- Innovate Newport and the New England Medical Innovation …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 04:39 GMT

CCRPS Revolutionizes Clinical Research Assistant Training with Comprehensive 114-Module Curriculum and Career Center

NEW YORK, NY, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- CCRPS, internationally recognized as a leader in clinical research education, is thrilled to announce substantial enhancements to its acclaimed Clinical Research Assistant …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 04:39 GMT

CRPS Expands Medical Science Liaison Training With Weekly Live Webinars, Career Center, Job Board, & Mentorship Support

CCRPS enhances Medical Science Liaison Certification with live webinars, career center, mentorship, job board—accelerating alumni into top MSL roles globally. NEW YORK, NY, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- CCRPS, renowned …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 04:09 GMT

Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Insights 2025: Trends, Size & Growth Forecast

The Business Research Company’s Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Global Market Report 2025 - Market Size, Trends, And Global Forecast 2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /⁨EINPresswire.com⁩/ -- The Business …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on May 29, 2025 - 00:00 GMT

ImagineHealth and Constance Care Partner to Bring Innovative Neuromodulation Technology to Poland

BANGKOK, BANGKOK, THAILAND, May 29, 2025 /⁨EINPresswire.com⁩/ -- ImagineHealth, Thailand’s leading longevity medicine facilitator, is proud to announce a strategic partnership with Constance Care, Poland’s premier neuro-rehabilitation center. This …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 28, 2025 - 23:00 GMT

Male Infertility Market Projected to Reach 6.62 Billion by 2033 | DataM Intelligence

Male infertility market size reached US$ 4.33 Bn in 2024 and is expected to reach US$ 6.62 Bn by 2033, growing at a CAGR of 4.9% during 2025-2033. NEW YORK, NY, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global male infertility market …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 28, 2025 - 22:49 GMT

Freedom Confectionery announces B Corp Certification, strengthening its role as the world’s most inclusive sweet brand

Freedom Confectionery announces B Corp Certification, becoming the only brand in its category to meet top ethical, sustainable, and inclusive standards LOS ANGELES, CA, UNITED STATES, May 28, 2025 /⁨EINPresswire.com⁩/ -- Freedom Confectionery LLC, …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...
Published on May 28, 2025 - 22:30 GMT

Genetic Testing Market to Witness Robust Growth at a CAGR of 23.1% by 2033 | DataM Intelligence

Genetic Testing Market- Innovative technologies, shifting patient preferences, and supportive government policies fuel market expansion across key regions CALIFORNIA, CA, UNITED STATES, May 29, 2025 /⁨EINPresswire.com⁩/ -- The global genetic …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 28, 2025 - 21:10 GMT

Nourify & Beautify Podcast Unveils New Logo, Website; Invites Nutraceutical and Cosmetic Founders to Be Featured Guests

Nourify & Beautify launches a new look, opens guest slots for founders, and invites subscribers to join its mission for safer, smarter beauty and wellness. IRVINE, CA, UNITED STATES, May 28, 2025 /⁨EINPresswire.com⁩/ -- Nourify & Beautify, …

Distribution channels: Beauty & Hair Care, Chemical Industry ...
Published on May 28, 2025 - 21:03 GMT

Kent County High School Art Society Students Deck the Halls at Chestertown Nursing and Rehab

Kent County High School Art Society Students Deck the Halls at Chestertown Nursing and Rehab MARLTON, NJ, UNITED STATES, May 28, 2025 /⁨EINPresswire.com⁩/ -- About a dozen art society students from Kent County High School spent the afternoon at …

Distribution channels: Companies, Education ...